Evidence map›Paper›PMID 34022250›Full record

Observational studyThe Journal of pediatrics2021

Chronic Hepatitis Is Common and Often Untreated Among Children with Hepatitis B Infection in the United States and Canada.

Simon C Ling, Hsing-Hua S Lin, Karen F Murray, Philip Rosenthal, Douglas Mogul, Norberto Rodriguez-Baez, Sarah Jane Schwarzenberg, Jeffrey Teckman, Kathleen B Schwarz, Hepatitis B Research Network (HBRN)

Abstract readObservational Study
In one paragraph

Observational study in The Journal of pediatrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Simon C LingDepartment of Paediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. Electronic address: simon.ling@sickkids.ca.
Hsing-Hua S LinDepartment of Epidemiology, University of Pittsburgh, Pittsburgh, PA.
Karen F MurrayDepartment of Pediatrics, University of Washington, Seattle, WA.
Philip RosenthalDepartment of Pediatrics, UCSF, San Francisco, CA.
Douglas MogulDepartment of Pediatrics, Johns Hopkins Medical Institutions, Baltimore, MD.
Norberto Rodriguez-BaezDepartment of Pediatrics, UT Southwestern, Dallas, TX.
Sarah Jane SchwarzenbergDepartment of Pediatrics, University of Minnesota Masonic Children's Hospital, Minneapolis, MN.
Jeffrey TeckmanDepartment of Pediatrics, Saint Louis University, Saint Louis, MO.
Kathleen B SchwarzDepartment of Pediatrics, Johns Hopkins Medical Institutions, Baltimore, MD.
Hepatitis B Research Network (HBRN)

Funding

Engaging University of California Stakeholders for Biorespository ResearchUL1TR000004 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$78.0M
Institute of Translational Health SciencesUL1TR000423 · NCATS · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2012 to 2016
$49.4M
Hepatitis B Research Network - Data Coordination CenterU01DK082864 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BELLE, STEVEN H. · 2008 to 2019
$25.3M
Hepatitis B Research Network (HBRN): Natural History and Treatment StudiesU01DK082944 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COOPER, STEWART, KHALILI, MANDANA · 2008 to 2019
$10.0M
Observation Study of Persons with Chronic Hepatitis B Virus infection in North AmericaU01DK082874 · NIDDK · UNIVERSITY HEALTH NETWORK · PI JANSSEN, HARRY · 2008 to 2019
$6.9M
Immunologic and Virologic Correlates of the Age-Related Decrease in HBV DNA in ChildrenU01DK082916 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI MURRAY, KAREN F, RODRIGUEZ BAEZ, NORBERTO · 2008 to 2019
$5.0M
Midwest Hepatitis B ConsortiumU01DK082871 · NIDDK · SAINT LOUIS UNIVERSITY · PI DI BISCEGLIE, ADRIAN MICHAEL · 2008 to 2019
$4.7M
Optimal Long-term Outcome of Chronic Hepatitis BU01DK082843 · NIDDK · MAYO CLINIC ROCHESTER · PI ROBERTS, LEWIS R · 2008 to 2014
$2.0M
NCATS NIH HHS UL1 TR000004NCATS NIH HHS UL1 TR000423NIDDK NIH HHS U01 DK082843NIDDK NIH HHS U01 DK082864NIDDK NIH HHS U01 DK082871NIDDK NIH HHS U01 DK082874NIDDK NIH HHS U01 DK082916NIDDK NIH HHS U01 DK082944
6 · The paper itself

Abstract

objectiveTo determine the outcomes of chronic hepatitis B virus (HBV) infection in a large, prospectively studied cohort of children in the US and Canada. STUDY

designThis was a prospective, observational study of children with chronic HBV enrolled in 7 clinical centers and evaluated at baseline, weeks 24 and 48, and annually thereafter, with analysis of demographic, clinical, physical examination, and blood test data.

resultsAmong 362 children followed for a median of 4.2 years, elevated alanine aminotransferase (ALT) levels (>1 upper limit of normal) were present in 72% at last evaluation, including in 60% of children with loss of hepatitis B e antigen during follow-up and 70% of those who were hepatitis B e antigen negative at baseline. Significant ALT flares (male patients ≥400 U/L, female patients ≥350 U/L) occurred in 13 children. Of 129 children who fulfilled the American Association for the Study of Liver Diseases treatment criteria during follow-up, anti-HBV treatment was initiated in only 25. One child died (unrelated to liver disease), 1 developed cirrhosis, but no episodes of cirrhotic decompensation or hepatocellular carcinoma were observed. Decline in platelet count was inversely associated with ALT elevations.

conclusionsIn a cohort of children with chronic HBV infection in the US and Canada, many children remained at risk of progressive liver disease due to active hepatitis, but major clinical outcomes such as cirrhosis, cancer, and death were rare. Many children who met criteria for treatment remained untreated.

Indexed as

AdolescentAntiviral AgentsBiomarkersCanadaChildChild, PreschoolDisease ProgressionFemaleFollow-Up StudiesHepatitis B, ChronicHumansInfantKaplan-Meier EstimateMalePractice Patterns, Physicians'Prospective StudiesAntiviral AgentsBiomarkersalanine aminotransferaseclinical outcomesentecavirinterferonlamivudinephenotypeplatelet countvertical transmission

Identifiers

PMID34022250
PMCPMC8478804

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.